Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
TRQ----eom
thanks for the info!--eom
TRQ-at 6k a tonne copper-150,000 tons =? 700,000 ounces gold x 1200 an ounce? any...
any help? thinking of buying more--$6,000.00 x 150,000 and
$1,200.00 x 700,000?
TRQ-at 6k a tonne copper-150,000 tons =? 700,000 ounces gold x 1200 an ounce? any...
any help? thinking of buying more--$6,000.00 x 150,000 and
$1,200.00 x 700,000?
TRQ-at 6k a tonne copper-150,000 tons =? 700,000 ounces gold x 1200 an ounce? any...
any help? thinking of buying more--$6,000.00 x 150,000 and
$1,200.00 x 700,000?
TRQ-150,000 tonnes of copper--700,000 ounces of gold--lol--that has to be a lot of money-calculator will not go that far--lol
TRQ-150,000 tonnes of copper--700,000 ounces of gold--lol--that has to be a lot of money-calculator will not go that far--lol
TRQ-150,000 tonnes of copper--700,000 ounces of gold--lol--that has to be a lot of money-calculator will not go that far--lol
TRQ-read all their news today-coming off 52 week low--eom
TRQ-read all their news today-coming off 52 week low--eom
TRQ-3.17--huge news out!! eom
TRQ-3.17--huge news out!! eom
TRQ-3.17--huge news out!! eom
TRQ-3.17--huge news out!! eom
HOV--should continue green this week---huge Q out last Thursday--g/l
HOV--should continue green this week---huge Q out last Thursday--g/l
HOV--should continue green this week---huge Q out last Thursday--g/l
HOV--a must read breaking out hard- http://finance.yahoo.com/news/builder-hovnanian-says-u-early-200200173.html
HOV--a must read breaking out hard- http://finance.yahoo.com/news/builder-hovnanian-says-u-early-200200173.html
HOV-breaking out hard on yesterday great Q---eom
HOV-breaking out hard on yesterday great Q---eom
HOV-breaking out hard on yesterday great Q---eom
HOV-homebuilder-huge Q yesterday-now this great news this morning--
from investor's business daily read
.
View Bright Through 2015
The rebound should continue into the next couple of years, as analysts expect Hovnanian to deliver robust profit gains in both fiscal 2014 and fiscal 2015
HOV-homebuilder-huge Q yesterday-now this great news this morning--
from investor's business daily read
.
View Bright Through 2015
The rebound should continue into the next couple of years, as analysts expect Hovnanian to deliver robust profit gains in both fiscal 2014 and fiscal 2015
HOV-homebuilder-huge Q yesterday-now this great news this morning--
from investor's business daily read
.
View Bright Through 2015
The rebound should continue into the next couple of years, as analysts expect Hovnanian to deliver robust profit gains in both fiscal 2014 and fiscal 2015
HOV homebuilder going to breaking out on huge Q--jmho--eom
HOV homebuilder going to breaking out on huge Q--jmho--eom
HOV homebuilder going to breaking out on huge Q--jmho--eom
HOV at 5.10--big Q today--might breakout up hard--eom
RJ!! eom
RSH-radio shack at 2.96--huge news for them!-- http://finance.yahoo.com/news/radioshack-closes-five-financing-totaling-001438702.html
RSH-radio shack at 2.96--huge news for them!-- http://finance.yahoo.com/news/radioshack-closes-five-financing-totaling-001438702.html
VICL-bought on pase 2 news today-did not realize the big pipleline- Vical Incorporated engages in the research and development of biopharmaceutical products based on its DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. Its products include Allovectin, a Phase III clinical trial product to treat metastatic melanoma; CyMVectin prophylactic vaccine for cytomegalovirus (CMV), which completed preclinical trial to prevent infection before pregnancy to preclude fetal transmission; and therapeutic and prophylactic vaccines for herpes simplex type 2 virus, which are under preclinical trial to prevent and protect against recurring flare-ups, reduce viral shedding, and transmission. The company, through corporate collaborations, develops TransVax, which is in Phase III clinical trial to protect against CMV infection after stem cell transplants, as well as in Phase II clinical trial to protect against CMV infection after solid organ transplants; Collategene, an angiogenic therapy encoding hepatocyte growth factor that is in Phase III clinical trials to induce local growth of blood vessels to restore blood flow to limbs affected by critical limb ischemia; Apex-IHN prophylactic vaccine for infectious hematopoietic necrosis virus, which is marketed for the prevention of infection and disease in farm-raised salmon when exposed to infected wild salmon in Canada; and ONCEPT therapeutic cancer vaccine encoding human tyrosinase for the treatment to enhance survival time of dogs with oral melanoma. Vical Incorporated, through government collaboration, develops prophylactic and/or therapeutic HIV vaccine, a Phase IIb clinical trial product to prevent/treat infection, disease, and/or viral shedding; and Tetravalent dengue vaccine, a Phase I clinical trial product to prevent dengue disease caused by all four dengue serotypes. The company was founded in 1987 and is headquartered in San Diego, California.
VICL-bought on pase 2 news today-did not realize the big pipleline- Vical Incorporated engages in the research and development of biopharmaceutical products based on its DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. Its products include Allovectin, a Phase III clinical trial product to treat metastatic melanoma; CyMVectin prophylactic vaccine for cytomegalovirus (CMV), which completed preclinical trial to prevent infection before pregnancy to preclude fetal transmission; and therapeutic and prophylactic vaccines for herpes simplex type 2 virus, which are under preclinical trial to prevent and protect against recurring flare-ups, reduce viral shedding, and transmission. The company, through corporate collaborations, develops TransVax, which is in Phase III clinical trial to protect against CMV infection after stem cell transplants, as well as in Phase II clinical trial to protect against CMV infection after solid organ transplants; Collategene, an angiogenic therapy encoding hepatocyte growth factor that is in Phase III clinical trials to induce local growth of blood vessels to restore blood flow to limbs affected by critical limb ischemia; Apex-IHN prophylactic vaccine for infectious hematopoietic necrosis virus, which is marketed for the prevention of infection and disease in farm-raised salmon when exposed to infected wild salmon in Canada; and ONCEPT therapeutic cancer vaccine encoding human tyrosinase for the treatment to enhance survival time of dogs with oral melanoma. Vical Incorporated, through government collaboration, develops prophylactic and/or therapeutic HIV vaccine, a Phase IIb clinical trial product to prevent/treat infection, disease, and/or viral shedding; and Tetravalent dengue vaccine, a Phase I clinical trial product to prevent dengue disease caused by all four dengue serotypes. The company was founded in 1987 and is headquartered in San Diego, California.
VICL--got more 1.10--on phase 2 news this morning--eom
VICL--got more 1.10--on phase 2 news this morning--eom
VICL-coming off bottom-great news-link http://finance.yahoo.com/news/astellas-vical-announce-initiation-phase-120000689.html
VICL-coming off bottom-great news-link http://finance.yahoo.com/news/astellas-vical-announce-initiation-phase-120000689.html